This article was originally published on Medtech Intelligence. Precision medicine, an emerging toolkit of ways to better understand the complex mechanisms underlying a patient’s health, disease, or condition, and to better predict which treatments will be most effective, has grown unevenly outside... Read More
Stymied by what they say is overzealous regulation, India’s’ drug companies are increasingly lobbying the government to reduce oversight of clinical trials, ease limits on new pharmaceutical ventures, and reduce regulations on new drugs. Pharma firms in India are big business. Currently... Read More
A new free trade agreement between Vietnam and the European Union grants foreign pharmaceutical companies the right to import drugs to this fast-growing Southeast Asian nation. Under the terms of the pact signed several months ago, foreign pharmaceutical companies designated as foreign... Read More
With clinical research and regulatory filings booming in China, regulatory authorities are receiving a record number of drug applications for new clinical trials and drug approvals. Last year, more than 5,500 applications for technical review were filed with China’s Center for Drug... Read More
The use of genetic or molecular profiling, known as precision medicine, is growing in popularity and usefulness throughout Asia, as doctors become more adept at selecting treatments that are most likely to help patients based on a genetic understanding of their disease.... Read More
Two years after Hainan Island, a popular Chinese tourist destination off the south coast of China, first emerged as a medical tourism hub, its authorities continue to grant special approval to foreign drugs and medical devices not legally available in mainland China.... Read More
Cancer killed almost 115,000 Vietnamese last year, as the burden of the disease continues its 30-year rise in the country, the World Health Organization reports. The most common type of cancer among men in Vietnam is liver cancer, followed by lung, stomach... Read More
Even as a fascination with new medical technologies powered by artificial intelligence (AI) increasingly takes hold in China, the country’s regulatory framework to manage this growth is still slowly evolving. Some Chinese hospitals are using robots to perform surgeries. Medical providers employ... Read More
Recently, China’s National Medical Products Administration moved to implement regulations on the development, production, and use of custom 3-D printed medical devices, as the new products rapidly grow in usefulness and popularity. The regulations – the first in China on custom medical... Read More
As demand skyrockets for healthcare in Southeast Asia, remote medical provider technologies are becoming increasingly popular. The technologies, which include app-based medical consultations and other telehealth options, allow doctors to reach more patients, especially in remote areas where access to healthcare providers... Read More